Investments in and Advances to Joint Ventures (Tables)

9 Months Ended

Sep. 30, 2022

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	September 30, 2022		December 31, 2021
Current assets	$	268,561	$	246,342
Noncurrent assets		7,885		2,180
Total assets		276,446		248,522
Current liabilities		169,233		175,637
Total liabilities		169,233		175,637
Total joint venture equity	$	107,213	$	72,885

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Revenue	$	130,344	$	101,816	$	333,967	$	296,685
Costs		101,882		86,726		289,485		260,129
Net income	$	28,462	$	15,090	$	44,482	$	36,556
Net income attributable to noncontrolling interests	$	14,024	$	7,411	$	21,685	$	17,711

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	September 30, 2022		December 31, 2021
Current assets	$	1,770,762	$	1,620,735
Noncurrent assets		487,823		531,261
Total assets		2,258,585		2,151,996
Current liabilities		1,357,131		1,088,985
Noncurrent liabilities		467,030		669,911
Total liabilities		1,824,161		1,758,896
Total joint venture equity	$	434,424	$	393,100
Investments in and advances to unconsolidated joint ventures	$	99,424	$	110,688

	Three Months Ended					Nine Months Ended
	September 30, 2022			September 30, 2021		September 30, 2022		September 30, 2021
Revenue	$	782,880		$	728,461	$	1,762,420	$	1,701,262
Costs		774,030			697,493		1,711,555		1,604,538
Net income	$	8,850		$	30,968	$	50,865	$	96,724
Equity in earnings of unconsolidated joint ventures	$	(974	)	$	9,570	$	10,237	$	26,528